A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia
Clinical trial NCT00773968 · COMPLETED
Trial details
- NCT number
- NCT00773968
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-03-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.